First-trimester atherogenic index of plasma and triglyceride–glucose indices in pregestational diabetes mellitus: associations with adverse pregnancy outcomes

Pregestational diabetes mellitus (PREGDM) confers a high risk of maternal and perinatal morbidity. Identifying early, reliable biomarkers is critical for risk stratification. The atherogenic index of plasma (AIP) and triglyceride–glucose (TyG) index are inexpensive metabolic markers reflecting dyslipidemia and insulin resistance, but their role in PREGDM remains underexplored. In this retrospective cohort study, medical records of 628 women (314 with PREGDM, 314 controls) delivering at a tertiary referral center were reviewed. First-trimester fasting blood samples were analyzed to calculate AIP [log₁₀(TG/HDL-C)] and TyG [ln(TG×glucose/2)]. Maternal and perinatal outcomes assessed included preeclampsia, preterm birth, macrosomia, fetal growth restriction (FGR), NICU admission, Apgar < 7 at 1 and 5 min, and a composite adverse perinatal outcome (CAPO). Logistic regression adjusted for age, BMI, parity, smoking, HbA1c, and fasting glucose; predictive ability was evaluated by ROC analysis. Compared with controls, women with PREGDM had significantly higher AIP (0.171 ± 0.207 vs. 0.148 ± 0.029, p < 0.001) and TyG (9.33 ± 0.65 vs. 8.90 ± 0.10, p < 0.001). PREGDM was associated with higher rates of preeclampsia (13.1% vs. 4.5%), preterm birth (21.7% vs. 10.8%), macrosomia (13.4% vs. 5.7%), FGR (8.3% vs. 3.8%), NICU admission (23.6% vs. 8.9%), and CAPO (29.3% vs. 9.9%) (all p < 0.01). In multivariate models, TyG independently predicted preterm birth (OR 1.62, 95% CI 1.28–2.04), macrosomia (OR 1.48, 95% CI 1.10–1.99), CAPO (OR 1.78, 95% CI 1.35–2.33), and low Apgar at 1 min (OR 1.84, 95% CI 1.40–2.42). AIP was inversely associated with FGR (OR 0.68, 95% CI 0.51–0.92). ROC analysis showed high accuracy of TyG for predicting low Apgar at 1 min (AUC 0.88) and NICU admission (AUC 0.76). Both AIP and TyG are elevated in PREGDM compared with controls. TyG is a robust predictor of preterm birth, macrosomia, neonatal compromise, and CAPO, whereas AIP provides complementary insight into vascular dysfunction and FGR in PREGDM group. These indices, easily derived from routine first-trimester tests, may offer practical tools for early obstetric risk stratification.

Authors

Institutions

Publication Details

Journal
BMC Pregnancy and Childbirth
Published
2025-11-22
DOI
https://doi.org/10.1186/s12884-025-08491-2
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-trimester atherogenic index of plasma and triglyceride–glucose indices in pregestational diabetes mellitus: associations with adverse pregnancy outcomes

Serenat Eriş Yalçın, Burcu Özkan Çetinkaya, Yakup Yalçın, Nuray Nerez
BMC Pregnancy and Childbirth
Gestational Diabetes Research and Management
article

First-trimester atherogenic index of plasma and triglyceride–glucose indices in pregestational diabetes mellitus: associations with adverse pregnancy outcomes

Serenat Eriş Yalçın, Burcu Özkan Çetinkaya, Yakup Yalçın, Nuray Nerez
article en

Abstract

Pregestational diabetes mellitus (PREGDM) confers a high risk of maternal and perinatal morbidity. Identifying early, reliable biomarkers is critical for risk stratification. The atherogenic index of plasma (AIP) and triglyceride–glucose (TyG) index are inexpensive metabolic markers reflecting dyslipidemia and insulin resistance, but their role in PREGDM remains underexplored. In this retrospective cohort study, medical records of 628 women (314 with PREGDM, 314 controls) delivering at a tertiary referral center were reviewed. First-trimester fasting blood samples were analyzed to calculate AIP [log₁₀(TG/HDL-C)] and TyG [ln(TG×glucose/2)]. Maternal and perinatal outcomes assessed included preeclampsia, preterm birth, macrosomia, fetal growth restriction (FGR), NICU admission, Apgar < 7 at 1 and 5 min, and a composite adverse perinatal outcome (CAPO). Logistic regression adjusted for age, BMI, parity, smoking, HbA1c, and fasting glucose; predictive ability was evaluated by ROC analysis. Compared with controls, women with PREGDM had significantly higher AIP (0.171 ± 0.207 vs. 0.148 ± 0.029, p < 0.001) and TyG (9.33 ± 0.65 vs. 8.90 ± 0.10, p < 0.001). PREGDM was associated with higher rates of preeclampsia (13.1% vs. 4.5%), preterm birth (21.7% vs. 10.8%), macrosomia (13.4% vs. 5.7%), FGR (8.3% vs. 3.8%), NICU admission (23.6% vs. 8.9%), and CAPO (29.3% vs. 9.9%) (all p < 0.01). In multivariate models, TyG independently predicted preterm birth (OR 1.62, 95% CI 1.28–2.04), macrosomia (OR 1.48, 95% CI 1.10–1.99), CAPO (OR 1.78, 95% CI 1.35–2.33), and low Apgar at 1 min (OR 1.84, 95% CI 1.40–2.42). AIP was inversely associated with FGR (OR 0.68, 95% CI 0.51–0.92). ROC analysis showed high accuracy of TyG for predicting low Apgar at 1 min (AUC 0.88) and NICU admission (AUC 0.76). Both AIP and TyG are elevated in PREGDM compared with controls. TyG is a robust predictor of preterm birth, macrosomia, neonatal compromise, and CAPO, whereas AIP provides complementary insight into vascular dysfunction and FGR in PREGDM group. These indices, easily derived from routine first-trimester tests, may offer practical tools for early obstetric risk stratification.

BMC Pregnancy and ChildbirthVol. 25(1)
Bursa Uludağ Üni̇versi̇tesi̇ (TR), Bursa Technical University (TR)
Openalex Percentile: Top 54%
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.